ICON Public Limited Company
NasdaqGS:ICLR
Sector
Industries
Location
Market Cap
USD 14.12 B
Share Price
USD 181.50
Avg Daily Volume
1,551,715
Change (1 day)
-2.00%
Change (1 year)
-45.08%
Change (YTD)
-13.45%
ICON Public Limited Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD 1.17 B
ICON Public Limited Company Operating Cash Flow is USD 1.17 B for the Trailing 12 Months (TTM) ending June 30, 2025, a -10.86% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
ICON Public Limited Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 1.31 B, a 146.22% change year over year.
-
ICON Public Limited Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 533.73 M, a -46.51% change year over year.
-
ICON Public Limited Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 997.75 M, a 82.16% change year over year.
-
ICON Public Limited Company Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 547.74 M, a -1.45% change year over year.
StockViz
Competitors
Boston Scientific Corporation
USD 106.76
BSX
+0.29
0.27%
Siemens Healthineers AG
USD 56.43
SHL.DE
+0.40
0.71%
GE HealthCare Technologies Inc.
USD 71.64
GEHC
-6.08
-7.82%
Laboratory Corporation of America Holdings
USD 263.91
LH
+2.19
0.84%
Natera, Inc.
USD 140.96
NTRA
+5.12
3.77%
Baxter International Inc.
USD 28.05
BAX
-0.79
-2.74%
Torrent Pharmaceuticals Limited
USD 42.20
TORNTPHARM.NS
-0.34
-0.79%
Ascendis Pharma A/S
USD 166.78
ASND
+3.46
2.12%
Exact Sciences Corporation
USD 46.80
EXAS
-0.74
-1.56%
Hangzhou Tigermed Consulting Co., Ltd.
USD 7.27
3347.HK
+0.01
0.19%
ConvaTec Group Plc
USD 3.06
CTEC.L
-0.20
-6.25%
Regencell Bioscience Holdings Limited
USD 14.43
RGC
+0.54
3.89%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.75
300832.SZ
-0.23
-2.84%
Laurus Labs Limited
USD 9.98
LAURUSLABS.NS
-0.07
-0.73%
APT Medical Inc.
USD 40.51
688617.SS
+0.52
1.31%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Boston Scientific Corporation
USD 106.76
BSX
+0.29
0.27%
Siemens Healthineers AG
USD 56.43
SHL.DE
+0.40
0.71%
GE HealthCare Technologies Inc.
USD 71.64
GEHC
-6.08
-7.82%
Laboratory Corporation of America Holdings
USD 263.91
LH
+2.19
0.84%
Natera, Inc.
USD 140.96
NTRA
+5.12
3.77%
Baxter International Inc.
USD 28.05
BAX
-0.79
-2.74%
Torrent Pharmaceuticals Limited
USD 42.20
TORNTPHARM.NS
-0.34
-0.79%
Ascendis Pharma A/S
USD 166.78
ASND
+3.46
2.12%
Exact Sciences Corporation
USD 46.80
EXAS
-0.74
-1.56%
Hangzhou Tigermed Consulting Co., Ltd.
USD 7.27
3347.HK
+0.01
0.19%
ConvaTec Group Plc
USD 3.06
CTEC.L
-0.20
-6.25%
Regencell Bioscience Holdings Limited
USD 14.43
RGC
+0.54
3.89%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.75
300832.SZ
-0.23
-2.84%
Laurus Labs Limited
USD 9.98
LAURUSLABS.NS
-0.07
-0.73%
APT Medical Inc.
USD 40.51
688617.SS
+0.52
1.31%